The Complicated Patenting of Our Psychedelic Future
This new project will bring psychedelic drugs to market much faster.
A new portal for patent reviewers called Porta Sophia aims to prevent psychedelic companies from filing overly broad and invalid patents. Bad patents can slow down the process of conducting clinical trials, which can hinder innovation and make the process more expensive. The portal makes it easy to find scientific literature and published patents in the psychedelic space so that companies can file quality patents and spend fewer resources fighting patent cases.